Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review

医学 前列腺癌 多学科方法 内科学 风险评估 妇科 肿瘤科 癌症 医学物理学 计算机科学 社会学 计算机安全 社会科学
作者
Lisa Moris,Marcus Cumberbatch,Thomas Van den Broeck,Giorgio Gandaglia,Nicola Fossati,B.D. Kelly,Raj P. Pal,Erik Briers,Philip Cornford,Maria De Santis,Stefano Fanti,Silke Gillessen,Jeremy Grummet,Ann Henry,Thomas Lam,Michael Lardas,Matthew Liew,Malcolm D. Mason,Muhammad Imran Omar,Olivier Rouvière,Ivo G. Schoots,Derya Tilki,Roderick C.N. van den Bergh,Theodorus H. van der Kwast,Henk G. van der Poel,Peter-Paul M. Willemse,Yuhong Yuan,Badrinath R. Konety,Tanya B. Dorff,Suneil Jain,Nicolas Mottet,Thomas Wiegel
出处
期刊:European Urology [Elsevier BV]
卷期号:77 (5): 614-627 被引量:121
标识
DOI:10.1016/j.eururo.2020.01.033
摘要

The optimal treatment for men with high-risk localized or locally advanced prostate cancer (PCa) remains unknown.To perform a systematic review of the existing literature on the effectiveness of the different primary treatment modalities for high-risk localized and locally advanced PCa. The primary oncological outcome is the development of distant metastases at ≥5 yr of follow-up. Secondary oncological outcomes are PCa-specific mortality, overall mortality, biochemical recurrence, and need for salvage treatment with ≥5 yr of follow-up. Nononcological outcomes are quality of life (QoL), functional outcomes, and treatment-related side effects reported.Medline, Medline In-Process, Embase, and the Cochrane Central Register of Randomized Controlled Trials were searched. All comparative (randomized and nonrandomized) studies published between January 2000 and May 2019 with at least 50 participants in each arm were included. Studies reporting on high-risk localized PCa (International Society of Urologic Pathologists [ISUP] grade 4-5 [Gleason score {GS} 8-10] or prostate-specific antigen [PSA] >20 ng/ml or ≥ cT2c) and/or locally advanced PCa (any PSA, cT3-4 or cN+, any ISUP grade/GS) or where subanalyses were performed on either group were included. The following primary local treatments were mandated: radical prostatectomy (RP), external beam radiotherapy (EBRT) (≥64 Gy), brachytherapy (BT), or multimodality treatment combining any of the local treatments above (±any systemic treatment). Risk of bias (RoB) and confounding factors were assessed for each study. A narrative synthesis was performed.Overall, 90 studies met the inclusion criteria. RoB and confounding factors revealed high RoB for selection, performance, and detection bias, and low RoB for correction of initial PSA and biopsy GS. When comparing RP with EBRT, retrospective series suggested an advantage for RP, although with a low level of evidence. Both RT and RP should be seen as part of a multimodal treatment plan with possible addition of (postoperative) RT and/or androgen deprivation therapy (ADT), respectively. High levels of evidence exist for EBRT treatment, with several randomized clinical trials showing superior outcome for adding long-term ADT or BT to EBRT. No clear cutoff can be proposed for RT dose, but higher RT doses by means of dose escalation schemes result in an improved biochemical control. Twenty studies reported data on QoL, with RP resulting mainly in genitourinary toxicity and sexual dysfunction, and EBRT in bowel problems.Based on the results of this systematic review, both RP as part of multimodal treatment and EBRT + long-term ADT can be recommended as primary treatment in high-risk and locally advanced PCa. For high-risk PCa, EBRT + BT can also be offered despite more grade 3 toxicity. Interestingly, for selected patients, for example, those with higher comorbidity, a shorter duration of ADT might be an option. For locally advanced PCa, EBRT + BT shows promising result but still needs further validation. In this setting, it is important that patients are aware that the offered therapy will most likely be in the context a multimodality treatment plan. In particular, if radiation is used, the combination of local with systemic treatment provides the best outcome, provided the patient is fit enough to receive both. Until the results of the SPCG15 trial are known, the optimal local treatment remains a matter of debate. Patients should at all times be fully informed about all available options, and the likelihood of a multimodal approach including the potential side effects of both local and systemic treatment.We reviewed the literature to see whether the evidence from clinical studies would tell us the best way of curing men with aggressive prostate cancer that had not spread to other parts of the body such as lymph glands or bones. Based on the results of this systematic review, there is good evidence that both surgery and radiation therapy are good treatment options, in terms of prolonging life and preserving quality of life, provided they are combined with other treatments. In the case of surgery this means including radiotherapy (RT), and in the case of RT this means either hormonal therapy or combined RT and brachytherapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
1秒前
廉凌波发布了新的文献求助10
2秒前
勤奋梨愁发布了新的文献求助10
3秒前
3秒前
潘善若发布了新的文献求助10
5秒前
caicai完成签到,获得积分10
6秒前
CodeCraft应助廉凌波采纳,获得10
7秒前
9秒前
仁爱水之完成签到 ,获得积分10
9秒前
丫丫完成签到,获得积分10
11秒前
11秒前
11秒前
prime发布了新的文献求助10
12秒前
雨过天晴发布了新的文献求助10
13秒前
14秒前
14秒前
14秒前
天天快乐应助玛卡巴卡采纳,获得30
15秒前
xiaohu完成签到,获得积分10
15秒前
zm发布了新的文献求助10
17秒前
温暖的冰菱关注了科研通微信公众号
17秒前
程程发布了新的文献求助10
17秒前
乖猫要努力应助感动黄豆采纳,获得10
18秒前
潘善若发布了新的文献求助10
20秒前
anna发布了新的文献求助10
21秒前
22秒前
充电宝应助momo采纳,获得10
22秒前
勤奋梨愁完成签到,获得积分10
23秒前
summer完成签到,获得积分10
23秒前
24秒前
深情安青应助程程采纳,获得10
26秒前
张雯思发布了新的文献求助10
26秒前
格格完成签到 ,获得积分10
29秒前
29秒前
Hello应助下一秒采纳,获得10
32秒前
天天快乐应助科研通管家采纳,获得10
33秒前
赘婿应助科研通管家采纳,获得10
33秒前
搜集达人应助科研通管家采纳,获得10
33秒前
桐桐应助科研通管家采纳,获得10
33秒前
科研通AI5应助科研通管家采纳,获得10
33秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989263
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253814
捐赠科研通 3270066
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882084
科研通“疑难数据库(出版商)”最低求助积分说明 809136